5 Short-Lived CEO Stints

Yet despite quick tenures, several execs still made a pretty penny

    View All  
5 Short-Lived CEO Stints

ceo1 5 Short Lived CEO StintsIn late July, Vivus (VVUS) appointed former AstraZeneca (AZN) executive Anthony Zook as its new CEO, settling Vivus’ proxy battle with First Manhattan Co. and Sarissa Capital Management.

But that didn’t last very long. Today, news broke that Zook has resigned because of recurring health issues.

Zook’s decision to leave after only a few weeks was his own — he noted that the choice was difficult, but that he “cannot devote the necessary time and focus to the company, but instead must concentrate on personal health issues.” Still, that ranks among the shortest of CEO tenures, many of whom left for reasons other than health.

And usually, that reason is that they’re doing a crappy job.

Here’s a look at five CEOs who were hired (and fired) in the relative blink of an eye. Take a look:


Article printed from InvestorPlace Media, http://investorplace.com/2013/09/5-sad-short-lived-ceo-stints/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.